Tenpoint Therapeutics is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company is addressing the ultimate cause of vision loss by replacing diseased cells with healthy ones to permanently restore vision. Learn more: www.tenpointtx.com.com/
Location: Belgium, Antwerp
Total raised: $70M
Investors 1
| Date | Name | Website |
| 12.07.2023 | F-Prime Ca... | fprimecapi... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.07.2023 | - | $70M | British Pa... | britishpat... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 13.07.2023 | British Patient Capital invests £10m in Tenpoint Therapeutic... | 12 July 2023: British Patient Capital has invested £10m in Tenpoint Therapeutics, an engineered cell... | britishpat... |
| 12.07.2023 | Tenpoint Therapeutics launches with $70M to restore vision w... | - | fprimecapi... |